Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CryoLife reports good results from meniscus study:

This article was originally published in Clinica

Executive Summary

CryoLife has reported that results from an eight-year follow-up study back the use of cryopreserved human meniscus cartilage for knee reconstructive surgery. Of 136 patients who had undergone total or partial meniscus replacement surgery using the cryopreserved cartilage, 90% said their surgery had been a success. The study was presented at the American Academy of Orthopaedic Surgeons in San Francisco earlier this month. In 1989, CryoLife initiated a programme for the recovery and cryopreservation of human meniscus tissue. Since then, the Atlanta, Georgia company has provided meniscus tissue to support more than 3,410 implant procedures in the US and Canada.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070287

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel